|
|
|
|
上一頁 9 10 11 12 13 14 15 16 17 18 ... Total pages:220 下一頁
(Taiwan) Yaung hopeful on H1N1 epidemic
(China Post, Taiwan)
17 September, 2009
The health minister struck an optimistic chord yesterday and affirmed his hope to see the A(H1N1) swine flu epidemic show signs of waning in the next week.
More...
|
|
|
|
|
(Taiwan) People with high BMI to get vaccine
(China Post, Taiwan)
11 September, 2009
Given recent studies observing obesity as one of the risk factors in contracting the A(H1N1) swine flu, health authorities recently announced that Taiwan residents with a body mass index (BMI) of over 35 would now be considered the latest priority group to be immunized, said local media yesterday.
More...
|
|
|
|
|
(Taiwan) Scientist sues bank
(Straits Times)
3 September, 2009
Well-known Taiwanese scientist Chang Tse Wen, who made his fortune developing an asthma drug, is suing Deutsche Bank in the High Court here after losing US$48million (S$69million) by investing in so-called 'accumulators'.
More...
|
|
|
|
|
(Taiwan) Research team wins science prize
(Taipei Times)
4 September, 2009
A research team composed of Taiwanese and French academics has won this year's Taiwan-France Science and Technology Award for their study on how to prevent proliferation of glial cells, or how to balance brain cell numbers, the National Science Council (NSC) announced on Wednesday.
More...
|
|
|
|
|
(China) China Medical Technologies still stumbling
(Seeking Alpha)
2 September, 2009
Over the past few years, China Medical Technologies (NSDQ: CMED) transformed itself from a company focused on a single medical device, the tumor-fighting High Intensity Focused Ultrasound machine, into a business with an attractive portfolio of in vitro diagnostic tests.
More...
|
|
|
|
|
(China) BioPharm plays up SF-China connection
(San Fransisco Business Times)
1 September, 2009
It may not have the crowded halls of the JPMorgan Healthcare Conference in January or the trade organization heft of October's BIO Investor Forum, but BioPharm America Sept. 15-18 promises something that the other well-established events can not: tie-ins to China and India.
More...
|
|
|
|
|
|
|
| |
